“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Create an account and get access to all information about NewAmsterdam Pharma Corporation
No Credit card required. Free Credit
No Credit card required. It’s fast, easy, and FREE! 🛠️
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
About
This page is intended for US audiences. Founded in 2019, NewAmsterdam Pharma Corporation is a late-stage clinical biopharmaceutical company focused on the research and development of transformative therapies for cardiometabolic diseases. Its mission is to improve patient care in populations where traditional therapies have been unsuccessful or are not tolerated. The Company is investigating a selective cholesteryl ester transfer protein (CETP) inhibitor as an LDL-C lowering therapy for patients who cannot be treated optimally with currently available lipid-lowering therapy or for patients with Atherosclerotic Cardiovascular Disease/Familial Hypercholesterolemia (ASCVD/FH) on maximally tolerated statin therapy
| C-Level 1 | VP - Level8 |
| Director21 | Manager9 |
| Others30 | |
| Structure | Email Format |
|---|---|
| <first>.<last>@ | John.Smith@bit.ly |
| <first>@ | John@bit.ly |
| Pain Points | Locations | Technologies |
|---|---|---|
| Build & Release | New Jersey, United States | communication, risk, integrity, scheduling, customer service, operations |
| Build & Release | United States | communication, e, root cause analysis, risk, integrity, compliance, collaboration, gmp |
| Compliance | New Jersey, United States | communication, risk, integrity, scheduling, customer service, operations |
| Compliance | United States | communication, e, root cause analysis, risk, integrity, compliance, collaboration, gmp |
| Database Administration | New Jersey, United States | communication, risk, integrity, scheduling, customer service, operations |
NewAmsterdam Pharma Corporation looking to hire in Digital Transformation in United States
NewAmsterdam Pharma Corporation looking to hire in Digital Transformation in Yardley, PA
NewAmsterdam Pharma Corporation looking to hire in Compliance in United States
Gcp
Access
Adp
Aws
Board
Ar
Assessment
Aws azure
Cgmp
Change control
Manager, Supply ChainNewAmsterdam is an innovative biotech company with the experience and expert...
View MoreNewAmsterdam is an innovative biotech company with the experience and expertise to deliver across...
View MoreNewAmsterdam is an innovative biotech company with the experience and expertise to deliver across...
View MoreManager, Supply ChainNewAmsterdam is an innovative biotech company with the experience and expert...
View MoreThis page is intended for US audiences. Founded in 2019, NewAmsterdam Pharma Corporation is a late-stage clinical biopharmaceutical company focused on the research and development of transformative therapies for cardiometabolic diseases. Its mission is to improve patient care in populations where traditional therapies have been unsuccessful or are not tolerated. The Company is investigating a selective cholesteryl ester transfer protein (CETP) inhibitor as an LDL-C lowering therapy for patients who cannot be treated optimally with currently available lipid-lowering therapy or for patients with Atherosclerotic Cardiovascular Disease/Familial Hypercholesterolemia (ASCVD/FH) on maximally tolerated statin therapy
Newamsterdam pharma corporation operates in the Biotechnology industry.
Newamsterdam pharma corporation's revenue is $45.56m
Newamsterdam pharma corporation has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.